These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31478429)

  • 1. Granuloma-like lesion at subcutaneous immunoglobulin site in a common variable immunodeficiency patient.
    Gupta A; Wang B; Gupta S
    Immunotherapy; 2019 Oct; 11(14):1177-1180. PubMed ID: 31478429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin (IVIG) efficiency in women with common variable immunodeficiency (CVID) decreases significantly during pregnancy.
    Egawa M; Kanegane H; Imai K; Morio T; Miyasaka N
    J Matern Fetal Neonatal Med; 2019 Sep; 32(18):3092-3096. PubMed ID: 29614902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal granuloma and immunoglobulin M-complex glomerulonephritis: a case of common variable immunodeficiency?
    Benoit G; Lapeyraque AL; Sartelet H; Saint-Cyr C; Le Deist F; Haddad E
    Pediatr Nephrol; 2009 Mar; 24(3):601-4. PubMed ID: 18696117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous immunoglobulin replacement therapy for primary antibody deficiency: advancements into the 21st century.
    Moore ML; Quinn JM
    Ann Allergy Asthma Immunol; 2008 Aug; 101(2):114-21; quiz 122-3, 178. PubMed ID: 18727465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Natural History of Untreated Primary Hypogammaglobulinemia in Adults: Implications for the Diagnosis and Treatment of Common Variable Immunodeficiency Disorders (CVID).
    Ameratunga R; Ahn Y; Steele R; Woon ST
    Front Immunol; 2019; 10():1541. PubMed ID: 31379811
    [No Abstract]   [Full Text] [Related]  

  • 6. New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin.
    Ameratunga R; Woon ST; Gillis D; Koopmans W; Steele R
    Clin Exp Immunol; 2013 Nov; 174(2):203-11. PubMed ID: 23859429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved IgG3 levels and reduced infection rate in a woman with CVID switched from intravenous to subcutaneous immunoglobulin therapy.
    Shapiro RS
    Immunotherapy; 2012 Dec; 4(12):1835-9. PubMed ID: 23240751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replacement and Immunomodulatory Activities of 20% Subcutaneous Immunoglobulin Treatment: A Single-Center Retrospective Study in Autoimmune Myositis and CVID Patients.
    Danieli MG; Verga JU; Mezzanotte C; Terrenato I; Svegliati S; Bilo MB; Moroncini G
    Front Immunol; 2021; 12():805705. PubMed ID: 35111165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practical aspects of immunoglobulin replacement.
    Ballow M
    Ann Allergy Asthma Immunol; 2017 Oct; 119(4):299-303. PubMed ID: 28958372
    [No Abstract]   [Full Text] [Related]  

  • 10. Granulomatous Uveitis and Conjunctivitis Due to Common Variable Immune Deficiency: A Case Report.
    Carter S; Xie K; Knight D; Minckler D; Kedhar S
    Ocul Immunol Inflamm; 2019; 27(7):1124-1126. PubMed ID: 30142001
    [No Abstract]   [Full Text] [Related]  

  • 11. [Subcutaneous gammaglobulin in common variable immunodeficiency. First experience in Spain].
    Maroto Hernando M; Soler Palacín P; Martin Nalda N; Oliveras Arenas M; Español Boren T; Figueras Nadal C
    An Pediatr (Barc); 2009 Feb; 70(2):111-9. PubMed ID: 19217565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypercalcemia in a patient with common variable immunodeficiency and renal granulomas.
    Meyer A; Lachmann HJ; Webster AD; Burns A; Thway K
    Am J Kidney Dis; 2005 May; 45(5):e90-3. PubMed ID: 15861342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcoid-like granulomas in common variable immunodeficiency.
    Artac H; Bozkurt B; Talim B; Reisli I
    Rheumatol Int; 2009 Nov; 30(1):109-12. PubMed ID: 19326121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Home therapy with subcutaneous immunoglobulins for patients with primary immunodeficiency diseases.
    Haddad É; Barnes D; Kafal A
    Transfus Apher Sci; 2012 Jun; 46(3):315-21. PubMed ID: 22503304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin Replacement Therapy for Primary Immunodeficiency.
    Sriaroon P; Ballow M
    Immunol Allergy Clin North Am; 2015 Nov; 35(4):713-30. PubMed ID: 26454315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study on CVID patients with adverse reactions to intravenous or subcutaneous IgG administration.
    Quinti I; Soresina A; Agostini C; Spadaro G; Matucci A; Sfika I; Martini H; Borghese F; Guerra A; Alessandra V; Visentini M; Plebani A; Fiorilli M
    J Clin Immunol; 2008 May; 28(3):263-7. PubMed ID: 18214651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous granulomas in common variable immunodeficiency: case report and review of literature.
    Aghamohammadi A; Abolhassani H; Rezaei N; Kalantari N; Tamizifar B; Cheraghi T; Parvaneh N; Yeganeh M; Moazzami K; Ebrahimi-Daryani N; Anaraki MR
    Acta Dermatovenerol Croat; 2010; 18(2):107-13. PubMed ID: 20624361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatigue and the wear-off effect in adult patients with common variable immunodeficiency.
    Hajjar J; Kutac C; Rider NL; Seeborg FO; Scalchunes C; Orange J
    Clin Exp Immunol; 2018 Dec; 194(3):327-338. PubMed ID: 30168848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin Necrosis Following Subcutaneous Immunoglobulin (SCIg).
    Carne E; Ponsford M; El-Shanawany T; Jolles S
    J Clin Immunol; 2017 Jan; 37(1):27-28. PubMed ID: 27796699
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of Diagnostic Criteria for Common Variable Immunodeficiency Disorders (CVID) in the New Zealand CVID Cohort Study.
    Ameratunga R; Longhurst H; Steele R; Woon ST
    Clin Rev Allergy Immunol; 2021 Oct; 61(2):236-244. PubMed ID: 34236581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.